5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine

C102H112Br3N39O16S — CID 158979015

IUPAC5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine
SMILESCC(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(Br)nc1-c1nc2ccccn2n1.CC(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(C2=CCN(C(=O)OC(C)(C)C)CC2)nc1-c1nc2ccccn2n1.CCS(=O)(=O)N1CC=C(c2cnc(N)c(-c3nc4ccccn4n3)n2)CC1.COC(=O)c1nc(Br)cnc1N.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nc2ccccn2n1.Nc1ncc(C2=CCNCC2)nc1-c1nc2ccccn2n1
InChIInChI=1S/C29H37N7O6.C19H21BrN6O4.C17H19N7O2S.C15H15N7.C10H7BrN6.C6H6BrN3O2.C6H7N3O2/c1-18(2)40-26(38)36(27(39)42-29(6,7)8)24-22(23-32-21-11-9-10-14-35(21)33-23)31-20(17-30-24)19-12-15-34(16-13-19)25(37)41-28(3,4)5;1-11(2)29-17(27)26(18(28)30-19(3,4)5)16-14(22-12(20)10-21-16)15-23-13-8-6-7-9-25(13)24-15;1-2-27(25,26)23-9-6-12(7-10-23)13-11-19-16(18)15(20-13)17-21-14-5-3-4-8-24(14)22-17;16-14-13(15-20-12-3-1-2-8-22(12)21-15)19-11(9-18-14)10-4-6-17-7-5-10;11-6-5-13-9(12)8(14-6)10-15-7-3-1-2-4-17(7)16-10;1-12-6(11)4-5(8)9-2-3(7)10-4;1-11-6(10)4-5(7)9-3-2-8-4/h9-12,14,17-18H,13,15-16H2,1-8H3;6-11H,1-5H3;3-6,8,11H,2,7,9-10H2,1H3,(H2,18,19);1-4,8-9,17H,5-7H2,(H2,16,18);1-5H,(H2,12,13);2H,1H3,(H2,8,9);2-3H,1H3,(H2,7,9)
InChIKeyJOTHVGSSAWOLFT-UHFFFAOYSA-N
MW2412.05 g/mol
LogP14.07
Rot. Bonds16

About 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine

5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine (PubChem CID 158979015) has the molecular formula C102H112Br3N39O16S and a molecular weight of 2412.05 g/mol. Its IUPAC name is 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine.

Molecular Properties

Compound Name5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine
PubChem CID158979015
Molecular FormulaC102H112Br3N39O16S
Molecular Weight2412.05 g/mol
Exact Mass2407.64
IUPAC Name5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine
SMILESCC(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(Br)nc1-c1nc2ccccn2n1.CC(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(C2=CCN(C(=O)OC(C)(C)C)CC2)nc1-c1nc2ccccn2n1.CCS(=O)(=O)N1CC=C(c2cnc(N)c(-c3nc4ccccn4n3)n2)CC1.COC(=O)c1nc(Br)cnc1N.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nc2ccccn2n1.Nc1ncc(C2=CCNCC2)nc1-c1nc2ccccn2n1
InChIInChI=1S/C29H37N7O6.C19H21BrN6O4.C17H19N7O2S.C15H15N7.C10H7BrN6.C6H6BrN3O2.C6H7N3O2/c1-18(2)40-26(38)36(27(39)42-29(6,7)8)24-22(23-32-21-11-9-10-14-35(21)33-23)31-20(17-30-24)19-12-15-34(16-13-19)25(37)41-28(3,4)5;1-11(2)29-17(27)26(18(28)30-19(3,4)5)16-14(22-12(20)10-21-16)15-23-13-8-6-7-9-25(13)24-15;1-2-27(25,26)23-9-6-12(7-10-23)13-11-19-16(18)15(20-13)17-21-14-5-3-4-8-24(14)22-17;16-14-13(15-20-12-3-1-2-8-22(12)21-15)19-11(9-18-14)10-4-6-17-7-5-10;11-6-5-13-9(12)8(14-6)10-15-7-3-1-2-4-17(7)16-10;1-12-6(11)4-5(8)9-2-3(7)10-4;1-11-6(10)4-5(7)9-3-2-8-4/h9-12,14,17-18H,13,15-16H2,1-8H3;6-11H,1-5H3;3-6,8,11H,2,7,9-10H2,1H3,(H2,18,19);1-4,8-9,17H,5-7H2,(H2,16,18);1-5H,(H2,12,13);2H,1H3,(H2,8,9);2-3H,1H3,(H2,7,9)
InChIKeyJOTHVGSSAWOLFT-UHFFFAOYSA-N
XLogP14.07
TPSA704.74 Ų
H-Bond Donors6
H-Bond Acceptors51
Rotatable Bonds16
Heavy Atoms161
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002412.05
LogP ≤ 514.07
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1051

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine?
The IUPAC name of 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine (CID 158979015) is 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine.
What is the SMILES notation for 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine?
The canonical SMILES for 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine is CC(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(Br)nc1-c1nc2ccccn2n1.CC(C)OC(=O)N(C(=O)OC(C)(C)C)c1ncc(C2=CCN(C(=O)OC(C)(C)C)CC2)nc1-c1nc2ccccn2n1.CCS(=O)(=O)N1CC=C(c2cnc(N)c(-c3nc4ccccn4n3)n2)CC1.COC(=O)c1nc(Br)cnc1N.COC(=O)c1nccnc1N.Nc1ncc(Br)nc1-c1nc2ccccn2n1.Nc1ncc(C2=CCNCC2)nc1-c1nc2ccccn2n1.
What is the InChIKey of 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine?
The InChIKey is JOTHVGSSAWOLFT-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H37N7O6.C19H21BrN6O4.C17H19N7O2S.C15H15N7.C10H7BrN6.C6H6BrN3O2.C6H7N3O2/c1-18(2)40-26(38)36(27(39)42-29(6,7)8)24-22(23-32-21-11-9-10-14-35(21)33-23)31-20(17-30-24)19-12-15-34(16-13-19)25(37)41-28(3,4)5;1-11(2)29-17(27)26(18(28)30-19(3,4)5)16-14(22-12(20)10-21-16)15-23-13-8-6-7-9-25(13)24-15;1-2-27(25,26)23-9-6-12(7-10-23)13-11-19-16(18)15(20-13)17-21-14-5-3-4-8-24(14)22-17;16-14-13(15-20-12-3-1-2-8-22(12)21-15)19-11(9-18-14)10-4-6-17-7-5-10;11-6-5-13-9(12)8(14-6)10-15-7-3-1-2-4-17(7)16-10;1-12-6(11)4-5(8)9-2-3(7)10-4;1-11-6(10)4-5(7)9-3-2-8-4/h9-12,14,17-18H,13,15-16H2,1-8H3;6-11H,1-5H3;3-6,8,11H,2,7,9-10H2,1H3,(H2,18,19);1-4,8-9,17H,5-7H2,(H2,16,18);1-5H,(H2,12,13);2H,1H3,(H2,8,9);2-3H,1H3,(H2,7,9).
What are the key properties of 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine?
5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine has a molecular weight of 2412.05 g/mol, XLogP of 14.07, 16 rotatable bonds, 6 hydrogen bond donors, and 51 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;tert-butyl 4-[5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-yloxycarbonylamino]-6-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylate;5-(1-ethylsulfonyl-3,6-dihydro-2H-pyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine;methyl 3-amino-6-bromopyrazine-2-carboxylate;methyl 3-aminopyrazine-2-carboxylate;propan-2-yl N-[5-bromo-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate;5-(1,2,3,6-tetrahydropyridin-4-yl)-3-([1,2,4]triazolo[1,5-a]pyridin-2-yl)pyrazin-2-amine is sourced from PubChem (CID 158979015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).